journal article·2026-03-25

Self-Strengthened PDT Coupling ROS Precise Regulation High-Penetration Microneedle for Adaptive Treatment of Pathological Scar

Yan Shi, Jinrui Li, Jiaxuan Zhao, Lu Liu, Ruimin Zhan, Dandan Jing, Xiaoya Wang, Dongwei Ma, Junmin Lee, Zhiguo Wang, Ming Kong

ACS Applied Materials & Interfaces· Volume 18· Issue 11
Publisher page

Abstract

Pathological scars are fibrotic disorders arising from aberrant wound healing. PDT is effective but limited by a dense matrix, hypoxia, and post-PDT excessive ROS-induced secondary inflammation. To address this, a NIR-switchable ROS-regulatory liposome (ICC@Lip) with CaO 2 NPs (oxygenation to strengthen PDT) and Cu 5.4 O nanozymes (ROS scavenging) was developed. In addition, inspired by Cyperaceae stems and triangular arrows, a highly penetrable biomimetic microneedle platform loaded with ICC@Lip and collagenase I (ICC@Lip/HPMN) was constructed to realize efficient transdermal cargo delivery and diffusion into a rigid pathological scar matrix. The puncture resistance of ICC@Lip/HPMN was only 56.4% that of conventional rectangular pyramid microneedles, with an effective puncture rate of 96% in mouse skin. In vitro, under NIR irradiation-mediated PDT/PTT, ICC@Lip significantly alleviated intracellular hypoxia and related fibrotic indicators, achieving a cytotoxicity rate of 93.71% against myofibroblasts─1.49-fold higher than that of the IR808 alone group (62.74%)─while reducing M2 macrophage polarization and TGF-β secretion. Notably, timely post-PDT ROS clearance decreased M1 polarization of macrophages and reduced the release of over 50% of inflammatory cytokines. In rabbit ear, a hypertrophic scar model exhibited that ICC@Lip/HPMN reduced the scar elevation index from 3 to 1.7, significantly alleviating collagen deposition and inflammation. The antifibrotic efficacies were majorly exerted through cross-downregulation of TGF-β, IL-4, and toll-like receptor signaling pathways. This study provided a promising adaptive therapeutic strategy of self-strengthened PDT coupling ROS precise regulation for pathological scars.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Advancements in Transdermal Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Marine Life Science

Ocean University of China

Department of Materials Science and Engineering

Pohang University of Science and Technology

Department of Burn and Plastic Surgery

The Affiliated Hospital of Qingdao University, Qingdao University

Funding

Qingdao Municipal Science and Technology Bureau · Natural Science Foundation of Shandong Province

References (72)

Show source-provided references
1. 10.1016/j.matbio.2016.01.01310.1016/j.matbio.2016.01.013 ↗
2. 10.1038/s41580-024-00716-010.1038/s41580-024-00716-0 ↗
3. 10.3389/fimmu.2024.135151310.3389/fimmu.2024.1351513 ↗
4. 10.1111/ddg.1427910.1111/ddg.14279 ↗
5. 10.1097/00006534-200208000-0003110.1097/00006534-200208000-00031 ↗
6. 10.1016/j.jccw.2016.10.00110.1016/j.jccw.2016.10.001 ↗
7. 10.2147/ccid.S3525210.2147/ccid.S35252 ↗
8. 10.1016/j.burns.2018.08.01110.1016/j.burns.2018.08.011 ↗
9. 10.1038/s42003-020-0922-410.1038/s42003-020-0922-4 ↗
10. 10.3389/fimmu.2022.94064510.3389/fimmu.2022.940645 ↗
11. 10.1016/j.semcdb.2019.10.01410.1016/j.semcdb.2019.10.014 ↗
12. 10.1186/s13287-018-0786-410.1186/s13287-018-0786-4 ↗
13. 10.1089/crispr.2018.004710.1089/crispr.2018.0047 ↗
14. 10.1016/j.matbio.2018.01.02010.1016/j.matbio.2018.01.020 ↗
15. 10.1016/j.pdpdt.2017.06.01010.1016/j.pdpdt.2017.06.010 ↗
16. 10.3389/fchem.2024.138939910.3389/fchem.2024.1389399 ↗
17. 10.1177/205951312093205910.1177/2059513120932059 ↗
18. 10.1371/journal.pone.005197410.1371/journal.pone.0051974 ↗
19. 10.1016/j.eti.2023.10309810.1016/j.eti.2023.103098 ↗
20. 10.1016/j.jconrel.2022.01.04310.1016/j.jconrel.2022.01.043 ↗
21. 10.1111/dsu.1247410.1111/dsu.12474 ↗
22. 10.3892/ijmm.2016.281610.3892/ijmm.2016.2816 ↗
23. 10.1016/j.redox.2020.10181510.1016/j.redox.2020.101815 ↗
24. 10.1016/j.jid.2020.01.03610.1016/j.jid.2020.01.036 ↗
25. 10.1186/s12964-023-01214-010.1186/s12964-023-01214-0 ↗
26. 10.1016/j.pdpdt.2024.10404010.1016/j.pdpdt.2024.104040 ↗
27. 10.1002/advs.20230518310.1002/advs.202305183 ↗
28. 10.1021/acsami.3c1099410.1021/acsami.3c10994 ↗
29. 10.1021/acsami.5c0063510.1021/acsami.5c00635 ↗
30. 10.5021/ad.2015.27.5.50710.5021/ad.2015.27.5.507 ↗
31. 10.1016/j.heliyon.2023.e1862910.1016/j.heliyon.2023.e18629 ↗
32. 10.1016/j.gene.2024.14907810.1016/j.gene.2024.149078 ↗
33. 10.1002/smll.20250688610.1002/smll.202506886 ↗
34. 10.1002/bmm2.1204410.1002/bmm2.12044 ↗
35. 10.1002/bmm2.7000110.1002/bmm2.70001 ↗
36. 10.1016/j.hlife.2024.07.00510.1016/j.hlife.2024.07.005 ↗
37. 10.1016/j.biomaterials.2024.12274210.1016/j.biomaterials.2024.122742 ↗
38. 10.1038/s41467-024-46328-210.1038/s41467-024-46328-2 ↗
39. 10.1038/s41467-023-39129-610.1038/s41467-023-39129-6 ↗
40. 10.1002/adfm.20230057510.1002/adfm.202300575 ↗
41. 10.1002/adma.20240615310.1002/adma.202406153 ↗
42. 10.1093/rb/rbaf09210.1093/rb/rbaf092 ↗
43. 10.1021/acsnano.1c1101610.1021/acsnano.1c11016 ↗
44. 10.1016/0305-4179(96)00038-110.1016/0305-4179(96)00038-1 ↗
45. 10.1016/j.jconrel.2022.11.04610.1016/j.jconrel.2022.11.046 ↗
46. 10.1002/adma.20220783210.1002/adma.202207832 ↗
47. 10.1016/j.matt.2021.11.02110.1016/j.matt.2021.11.021 ↗
48. 10.1177/0954411922113713310.1177/09544119221137133 ↗
49. 10.1016/j.mtcomm.2024.11057310.1016/j.mtcomm.2024.110573 ↗
50. 10.1002/ajb2.155810.1002/ajb2.1558 ↗
51. 10.1016/j.bioadv.2023.21365910.1016/j.bioadv.2023.213659 ↗
52. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
53. 10.1002/smll.20190211810.1002/smll.201902118 ↗
54. 10.1002/smll.20170162110.1002/smll.201701621 ↗
55. 10.1016/j.bbadis.2024.16749910.1016/j.bbadis.2024.167499 ↗
56. 10.1016/j.mtbio.2025.10157210.1016/j.mtbio.2025.101572 ↗
57. 10.1016/S0142-9612(02)00207-710.1016/S0142-9612(02)00207-7 ↗
58. 10.1002/anie.20200410410.1002/anie.202004104 ↗
59. 10.1007/s00403-024-03352-y10.1007/s00403-024-03352-y ↗
60. 10.1074/jbc.M80090220010.1074/jbc.M800902200 ↗
61. 10.1038/s41573-024-00979-410.1038/s41573-024-00979-4 ↗
62. 10.1097/SCS.000000000001047910.1097/SCS.0000000000010479 ↗
63. 10.1038/s41467-023-42058-z10.1038/s41467-023-42058-z ↗
64. 10.1038/sj.jid.570056410.1038/sj.jid.5700564 ↗
65. 10.1016/j.bbrc.2016.09.15910.1016/j.bbrc.2016.09.159 ↗
66. 10.4049/jimmunol.178.8.528810.4049/jimmunol.178.8.5288 ↗
67. 10.1046/j.1524-475X.2002.10609.x10.1046/j.1524-475X.2002.10609.x ↗
68. 10.1161/circresaha.107.16040810.1161/circresaha.107.160408 ↗
69. 10.1002/hep.3158210.1002/hep.31582 ↗
70. 10.1186/s41038-019-0175-y10.1186/s41038-019-0175-y ↗
71. 10.1038/srep3223110.1038/srep32231 ↗
72. 10.1021/acsnano.2c0385810.1021/acsnano.2c03858 ↗